title: Babesia microti infection in Europe.
abstract: The majority of babesia infections in Europe are life-threatening and caused by Babesia divergens and B. bovis. Although Babesia microti has been detected in ticks from Switzerland, few if any cases of babesiosis have been caused by B. microti. This first reported case, diagnosed by serology, DNA detection, and microscopy, is additionally interesting because there appears to be coinfection with the Lyme disease organism, Borrelia burgdorferi.
authors.affiliation: Medical Diagnostic Laboratories, Mt. Laurel, NJ, USA.
authors.forename: Laurence
authors.initials: L
authors.lastname: Meer-Scherrer
authors.forename: Martin
authors.initials: M
authors.lastname: Adelson
authors.forename: Eli
authors.initials: E
authors.lastname: Mordechai
authors.forename: Beatrice
authors.initials: B
authors.lastname: Lottaz
authors.forename: Richard
authors.initials: R
authors.lastname: Tilton
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial / Q000097:blood; D000913:Antibodies, Protozoan / Q000097:blood; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D041001:Babesia microti / Q000166:cytology / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification*; D001404:Babesiosis / Q000150:complications / Q000188:drug therapy / Q000469:parasitology; D025065:Borrelia burgdorferi / Q000276:immunology / Q000302:isolation & purification; D004269:DNA, Bacterial / Q000097:blood; D016054:DNA, Protozoan / Q000097:blood; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005060:Europe; D006801:Humans; D008193:Lyme Disease / Q000150:complications*; D008297:Male; D015767:Mefloquine / Q000008:administration & dosage / Q000627:therapeutic use; D008853:Microscopy
chemical_list: D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial; D000913:Antibodies, Protozoan; D000981:Antiprotozoal Agents; D004269:DNA, Bacterial; D016054:DNA, Protozoan; D015767:Mefloquine